Transcriptome Analysis Identifies GATA3-AS1 as a Long Noncoding RNA Associated with Resistance to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transcriptome Analysis Identifies GATA3-AS1 as a Long Noncoding RNA Associated with Resistance to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients
Authors
Keywords
-
Journal
JOURNAL OF MOLECULAR DIAGNOSTICS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-08-04
DOI
10.1016/j.jmoldx.2021.07.014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GATA3 somatic mutations are associated with clinicopathological features and expression profile in TCGA breast cancer patients
- (2021) Fahimeh Afzaljavan et al. Scientific Reports
- Variability in estimated gene expression among commonly used RNA-seq pipelines
- (2020) Sonali Arora et al. Scientific Reports
- Neural Functions Play Different Roles in Triple Negative Breast Cancer (TNBC) and non-TNBC
- (2020) Renbo Tan et al. Scientific Reports
- The lncRNA-GAS5/miR-221-3p/DKK2 Axis Modulates ABCB1-Mediated Adriamycin Resistance of Breast Cancer via the Wnt/β-Catenin Signaling Pathway
- (2020) Zhaolin Chen et al. Molecular Therapy-Nucleic Acids
- LncRNA GATA3‐AS1 facilitates tumour progression and immune escape in triple‐negative breast cancer through destabilization of GATA3 but stabilization of PD‐L1
- (2020) Ming Zhang et al. CELL PROLIFERATION
- The Relationship of GATA3 and Ki-67 With Histopathological Prognostic Parameters, Locoregional Recurrence and Disease-free Survival in Invasive Ductal Carcinoma of the Breast
- (2020) EMINE YILDIRIM et al. ANTICANCER RESEARCH
- Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation
- (2020) Marco Napoli et al. Nature Communications
- Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer
- (2020) Mieke R. Van Bockstal et al. Annals of Diagnostic Pathology
- Liquid biopsy and minimal residual disease — latest advances and implications for cure
- (2019) Klaus Pantel et al. Nature Reviews Clinical Oncology
- Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer
- (2019) Parveen Jain et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: a retrospective cohort analysis
- (2019) Jonathan Klein et al. BMC CANCER
- Identification of lnc RNA s associated with early‐stage breast cancer and their prognostic implications
- (2019) Arunagiri Kuha Deva Magendhra Rao et al. Molecular Oncology
- LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer
- (2019) Ying Zeng et al. Frontiers in Pharmacology
- LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
- (2019) Jie Luo et al. Nature Communications
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- Long Noncoding RNA GATA3-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Suppression of PTEN, CDKN1A, and TP53
- (2019) Xuee Luo et al. Canadian Journal of Gastroenterology and Hepatology
- A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
- (2018) Ashton C. Berger et al. CANCER CELL
- lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer
- (2018) Zehua Wang et al. CANCER CELL
- Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy
- (2018) Paula Cabrera‐Galeana et al. ONCOLOGIST
- Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis Competition
- (2018) Lingling Pian et al. Molecular Therapy-Nucleic Acids
- Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity
- (2018) Christopher Dravis et al. CANCER CELL
- A Minimal lncRNA-mRNA Signature Predicts Sensitivity to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
- (2018) Qian Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer
- (2018) Alma Campos-Parra et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review
- (2018) Madeline Pe et al. LANCET ONCOLOGY
- lncRNA profile study reveals the mRNAs and lncRNAs associated with docetaxel resistance in breast cancer cells
- (2018) Peide Huang et al. Scientific Reports
- Divergent lncRNA GATA3-AS1 Regulates GATA3 Transcription in T-Helper 2 Cells
- (2018) Hunter R. Gibbons et al. Frontiers in Immunology
- Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
- (2017) M.J. Duffy et al. EUROPEAN JOURNAL OF CANCER
- Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
- (2017) Matthew J. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Salmon provides fast and bias-aware quantification of transcript expression
- (2017) Rob Patro et al. NATURE METHODS
- Clinical utility of gene-expression signatures in early stage breast cancer
- (2017) Maryann Kwa et al. Nature Reviews Clinical Oncology
- A Long Noncoding RNA Signature That Predicts Pathological Complete Remission Rate Sensitively in Neoadjuvant Treatment of Breast Cancer
- (2017) Gen Wang et al. Translational Oncology
- The lncRNA BORG Drives Breast Cancer Metastasis and Disease Recurrence
- (2017) Alex J. Gooding et al. Scientific Reports
- RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy
- (2017) Debora Fumagalli et al. JAMA Oncology
- LncRNAs2Pathways: Identifying the pathways influenced by a set of lncRNAs of interest based on a global network propagation method
- (2017) Junwei Han et al. Scientific Reports
- Long Noncoding RNAs in Cancer Pathways
- (2016) Adam M. Schmitt et al. CANCER CELL
- Molecular Testing and the Pathologist's Role in Clinical Trials of Breast Cancer
- (2016) Hyo Sook Han et al. Clinical Breast Cancer
- The role of GATA3 in breast carcinomas: a review
- (2016) Rebecca Asch-Kendrick et al. HUMAN PATHOLOGY
- Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets
- (2016) Subash Chandra Gupta et al. INTERNATIONAL JOURNAL OF CANCER
- Unique features of long non-coding RNA biogenesis and function
- (2016) Jeffrey J. Quinn et al. NATURE REVIEWS GENETICS
- GATA-3 expression is not associated with complete pathological response in triple negative breast cancer patients treated with neoadjuvant chemotherapy
- (2016) Jason K. Wasserman et al. PATHOLOGY RESEARCH AND PRACTICE
- The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression
- (2016) Yashar S. Niknafs et al. Nature Communications
- Long non-coding RNAs in anti-cancer drug resistance
- (2016) Qin-nan Chen et al. Oncotarget
- Mammary Tumor-Associated RNAs Impact Tumor Cell Proliferation, Invasion, and Migration
- (2016) Sarah D. Diermeier et al. Cell Reports
- Long intergenic non-coding RNA expression signature in human breast cancer
- (2016) Yanfeng Zhang et al. Scientific Reports
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- (2015) A. S. Coates et al. ANNALS OF ONCOLOGY
- Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers
- (2015) Xiaohui Yan et al. CANCER CELL
- The Significance and Therapeutic Potential of GATA3 Expression and Mutation in Breast Cancer: A Systematic Review
- (2015) Feng Du et al. MEDICINAL RESEARCH REVIEWS
- The landscape of long noncoding RNAs in the human transcriptome
- (2015) Matthew K Iyer et al. NATURE GENETICS
- Management of locally advanced breast cancer—perspectives and future directions
- (2015) Konstantinos Tryfonidis et al. Nature Reviews Clinical Oncology
- LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer
- (2015) X Xue et al. ONCOGENE
- Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer
- (2015) Yi Shen et al. Oncotarget
- LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer
- (2015) Sheng-Jia Shi et al. Oncotarget
- A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients
- (2015) Jie Sun et al. Scientific Reports
- Genome-wide DNA methylome analysis reveals epigenetically dysregulated non-coding RNAs in human breast cancer
- (2015) Yongsheng Li et al. Scientific Reports
- Trimmomatic: a flexible trimmer for Illumina sequence data
- (2014) Anthony M. Bolger et al. BIOINFORMATICS
- Public health national approach to reducing breast and cervical cancer disparities
- (2014) Jacqueline W. Miller et al. CANCER
- Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling
- (2014) Yu Fan et al. FEBS Journal
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- Profiling of human CD4+ T-cell subsets identifies the TH2-specific noncoding RNA GATA3-AS1
- (2013) Huan Zhang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Clinicopathological analysis of GATA3-positive breast cancers with special reference to response to neoadjuvant chemotherapy
- (2012) N. Tominaga et al. ANNALS OF ONCOLOGY
- The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression
- (2012) T. Derrien et al. GENOME RESEARCH
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses
- (2011) M. N. Cabili et al. GENES & DEVELOPMENT
- Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer
- (2010) M F E Godinho et al. BRITISH JOURNAL OF CANCER
- Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
- (2010) Rajnish A. Gupta et al. NATURE
- CDK Inhibitor p18INK4c Is a Downstream Target of GATA3 and Restrains Mammary Luminal Progenitor Cell Proliferation and Tumorigenesis
- (2009) Xin-Hai Pei et al. CANCER CELL
- Convergent random forest predictor: Methodology for predicting drug response from genome-scale data applied to anti-TNF response
- (2009) Jadwiga R. Bienkowska et al. GENOMICS
- Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
- (2009) Jennifer Specht et al. SEMINARS IN RADIATION ONCOLOGY
- ConsensusPathDB—a database for integrating human functional interaction networks
- (2008) Atanas Kamburov et al. NUCLEIC ACIDS RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now